All Sections

Site Selection

Facility Planning

Workforce Development

Business+Place

AD Editorial Board

Alan Reeves

Senior Managing Director, Global Strategy, Newmark
Alexandra Segers

General Manager, Tochi Advisors
Amy Gerber

Executive Managing Director, Business Incentives Practice, Cushman & Wakefield
Bradley Migdal

Executive Managing Director, Americas Strategic Consulting, Cushman & Wakefield
Brian Corde

Managing Partner, Atlas Insight
Brian Gallagher

Vice President, Corporate Strategy and Development, PPC Partners, Inc.
Chris Chmura, Ph.D.

CEO & Founder, Chmura Economics
Chris Schwinden

Partner, Site Selection Group
Chris Volney

Managing Director, Americas Consulting, CBRE
Courtland Robinson

Director of Business Development, Brasfield & Gorrie
Courtney Dunbar

Site Selection & Economic Development Leader, Burns & McDonnell
David Hickey

Managing Director, Hickey & Associates
Dennis Cuneo

Former Senior Vice President, Toyota Motor North America; Owner , DC Strategic Advisors
Dianne Jones

Managing Director, Business and Economic Incentives, JLL
Eric Stavriotis

Vice Chairman, CBRE
Joe Dunlap

Chief Supply Chain Officer, Legacy Investing
Lauren Berry

Director, Location Analysis and Incentives, Maxis Advisors
Marc Beauchamp

President, SCI Global
Matthew Powers

Site Selection Lead, REDI Site Selection
Scott J. Ziance

Partner and Economic Incentives Practice Leader, Vorys, Sater, Seymour and Pease LLP
Scott Kupperman

Founder, Kupperman Location Solutions
Stephen Gray

President & CEO, Gray Construction

Becton, Dickinson and Company Expands Columbus, Nebraska, Operations

Area Development News Desk

02/15/2026

American medical technology and device manufacturer Becton, Dickinson and Company plans to expand its operations in Columbus, Nebraska. The $110 million project is expected to create approximately 120 jobs.

The investment at the company’s existing site will support production of Neopak Glass Prefillable Syringes and increase cannula manufacturing capabilities.

"As demand for biologics and GLP-1s accelerates, BD is strengthening its American manufacturing footprint to support U.S.-based drug delivery innovation and supply chain resiliency," said Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems. "This investment in Nebraska, advances our long-term growth strategy and reflects our commitment to partnering with biopharmaceutical innovators as they bring advanced therapies to patients who require next-generation drug delivery solutions."

Becton, Dickinson and Company (BD) develops, produces, and sells a broad portfolio of diagnostic instruments, medical supplies, and laboratory equipment. The company’s products include needles and syringes, infusion systems, diagnostic systems, and devices for medication management, serving hospitals, clinics, research labs, and public health organizations.

"This is another perfect example of a company with global reach producing high value, cutting edge products at its plant right here in Nebraska,” noted Nebraska Governor Jim Pillen. “We can compete with anyone in the world and we are the best at what we do because of our people. The announcement of this expansion for BD is exciting news."

Project Announcements